IL-12 engineered TIL
/ National Cancer Institute
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
August 07, 2013
Cell Therapy for Metastatic Melanoma Using CD8 Enriched Tumor Infiltrating Lymphocytes
(clinicaltrials.gov)
- P1/2; N=31; Suspended; Sponsor: National Cancer Institute (NCI); N=103 ➔ 31
Enrollment change
May 12, 2014
Cell Therapy for Metastatic Melanoma Using CD8 Enriched Tumor Infiltrating Lymphocytes
(clinicaltrials.gov)
- P1/2; N=34; Suspended; Sponsor: National Cancer Institute (NCI); Trial primary completion date: Oct 2014 ➔ Dec 2017
Trial primary completion date
1 to 2
Of
2
Go to page
1